topic for breast carcinoma and surgical resident here in the surgical oncology residency in Rajiv Gandhi Cancer Hospital DC. Tell me the easy topic to do in thesis. We do biopsy, PET scan, commonly we do MRM, BCS commonly, SLNB and ALND commonly.
Reading File
Finding Sources
Finding Sources
Searching PubMed
breast cancer AND sentinel lymph node biopsy
Searching the Web
breast cancer surgical oncology thesis topics sentinel lymph node biopsy breast conserving surgery prospective audit quality of life 2025 guideline
Reading File
Reading File
Reading Article
PMID: 40209128
Reading Web Page
https://pubmed.ncbi.nlm.nih.gov/40209128/
The easiest, practical thesis topic in your setup:
“Diagnostic accuracy of preoperative FDG PET-CT for axillary nodal metastasis in clinically node-negative early breast carcinoma, using sentinel lymph node biopsy histopathology as the reference standard.”
This fits your routine workflow: core biopsy -> PET-CT -> BCS/MRM with SLNB -> final histopathology. It needs no change in treatment, no expensive extra test, and can be done as a prospective observational study or, even more easily, as a retrospective-prospective study using existing records plus new cases.
Why this is a good resident thesis
- High feasibility: PET-CT and SLNB are already being done.
- Clear endpoint: compare PET axillary status with final SLN histopathology.
- Simple data collection: age, tumor size, grade, subtype, PET nodal findings, number of SLNs, SLN positivity, extracapsular extension if available.
- Straightforward statistics: sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and ROC analysis if you use SUVmax.
- Useful local data: PET performance may differ by tumor burden, subtype, size, and reporting protocol in your own patient population.
- You can finish it without needing long follow-up for recurrence or survival.
Suggested protocol
Population
- Newly diagnosed invasive breast carcinoma
- cT1-2, clinically node-negative axilla
- Planned upfront BCS/MRM with SLNB
- Preoperative PET-CT performed as part of routine institutional work-up
Exclude
- Neoadjuvant chemotherapy before SLNB
- Clinically node-positive axilla
- Prior axillary surgery
- Distant metastatic disease
- Missing PET or final pathology report
Primary objective
- To determine the diagnostic accuracy of PET-CT in detecting axillary lymph-node metastasis, with SLNB histopathology as the reference standard.
Secondary objectives
- Correlation of PET-positive axilla with number of involved SLNs.
- Association of PET accuracy with primary tumor size, grade, ER/PR/HER2 subtype, Ki-67, and lymphovascular invasion.
- Evaluation of SUVmax or PET morphologic features, if consistently reported.
- Estimation of occult nodal metastasis among PET-negative patients.
Important methods point: Do not call this a study of “false-negative rate of SLNB” because you will not be doing ALND in every SLNB-negative patient. Your reference standard is final SLNB histology, and you are measuring the diagnostic performance of PET-CT against that standard.
A sample size of roughly 100 to 150 eligible patients is usually realistic for a resident project, but have your biostatistician calculate it based on your expected SLN positivity rate and desired precision.
My ranking of easy topics for you
| Rank | Thesis topic | Difficulty | Comment |
|---|---|---|---|
| 1 | PET-CT versus SLNB histopathology for axillary staging in cN0 early breast cancer | Easy | Best fit if PET is routinely performed |
| 2 | Clinicopathological predictors of positive SLNB in clinically node-negative breast cancer | Very easy | Safest retrospective thesis, but less novel |
| 3 | Audit of BCS: margin positivity, re-excision rate, and predictors of positive margins | Easy | Excellent if pathology and operative records are reliable |
| 4 | Comparison of early arm morbidity after SLNB versus ALND | Moderate | Clinically meaningful, but requires standardized follow-up and lymphedema assessment |
| 5 | Pattern of discordance between PET-CT and final pathological stage in breast carcinoma | Easy-moderate | Broader than axilla, but can become messy unless tightly defined |
Best backup topic if PET reports are inconsistent
“Clinicopathological predictors of sentinel lymph node metastasis in clinically node-negative breast carcinoma: a single-center observational study.”
This is probably the lowest-risk thesis administratively. You can include all patients who underwent upfront SLNB and study tumor size, grade, lymphovascular invasion, histology, multifocality, receptor subtype, Ki-67, and imaging findings. The drawback is that it is a common topic, so add a practical angle such as a local predictive score or comparison with preoperative axillary ultrasound/PET findings.
Topic I would avoid
- MRM versus BCS survival comparison: difficult because of selection bias, differing stages, adjuvant treatment confounding, and long follow-up requirements.
- SLNB versus ALND oncologic outcomes: same problem, plus ALND indications are selective.
- PET-CT effect on survival: requires large numbers and prolonged follow-up.
- SLNB identification rate / false-negative rate: only worthwhile if you have a carefully standardized mapping protocol and enough completion ALNDs for validation.
Clinical relevance
Axillary surgery is used for staging through SLNB and for treatment in selected node-positive disease, while ALND carries more morbidity (Bailey and Love’s Short Practice of Surgery, p. 957). Current practice is moving toward de-escalation: the 2025 ASCO update states that routine SLNB can be omitted in a very selected low-risk group of postmenopausal women aged 50 years or older with negative axillary ultrasound, small grade 1-2 HR-positive/HER2-negative tumors undergoing breast-conserving therapy. It also advises against ALND for patients with one to two positive sentinel nodes receiving BCS and whole-breast radiotherapy in appropriate settings, as summarized in the ASCO guideline update. That makes a local study of imaging-pathology concordance timely, but it should remain observational and must not alter routine patient management solely for the thesis.
My final pick: choose the PET-CT versus SLNB histopathology study if your PET reports consistently document axillary findings. If not, choose predictors of positive SLNB.
This is a shared conversation. Sign in to Orris to start your own chat.